U.S. Court of Appeals for the Federal Circuit, 2014

Gilead Sciences, Inc. v. Sigmapharm Labs

Gilead Sciences, Inc. v. Sigmapharm Labs
U.S. Court of Appeals for the Federal Circuit · Decided December 8, 2014
Gilead Sciences, Inc. v. Sigmapharm Labs

Opinion

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit

______________________ GILEAD SCIENCES, INC., Plaintiff-Appellee, v.

SIGMAPHARM LABORATORIES, LLC,

Defendant-Appellant. ______________________ 2014-1456 ______________________

Appeal from the United States District Court for the District of New Jersey in No. 2:10-cv-04931-SDW-MCA, Judge Susan D. Wigenton.

______________________ JUDGMENT ______________________

TIMOTHY J. KELLY, Fitzpatrick, Cella, Harper & Scin- to, of New York, New York, argued for plaintiff-appellee. With him on the brief was CHRISTOPHER E. LOH. Of counsel was COLLEEN TRACY.

JOHN E. ROSENQUIST, Leydig, Voit & Mayer, LTD., of Chicago, Illinois, argued for defendant-appellant. With him on the brief was MARC R. WEZOWSKI. Of counsel on the brief were K. LEE MARSHALL and ROBERT L.

STOLEBARGER, Bryan Cave LLP, of San Francisco, Cali- fornia; and AMEER GADO and ANTHONY FRIEDMAN, of St. Louis, Missouri. Of counsel was KAREN A. CONFOY, Fox Rothschild, of Lawrenceville, New Jersey.

______________________

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (DYK, REYNA, and HUGHES, Circuit Judg- es).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT December 8, 2014 /s/ Daniel E. O’Toole

Date Daniel E. O’Toole

Clerk of Court

Case-law data current through September 30, 2026. Source: CourtListener bulk data.